|
Index of reports
> Cases with Pyrexia (163)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dexamethasone where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 163 Next >>
Possible Dexamethasone side effects in female
Reported by a physician from France on 2012-08-21
Patient: female, weighing 45.0 kg (99.0 pounds)
Reactions: Dyspnoea, Pleural Effusion, Pyrexia, Generalised Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bortezomib
Dosage: 1.82 milligram daily;
Indication: Mantle Cell Lymphoma
Start date: 2012-02-02
Dexamethasone
Indication: Mantle Cell Lymphoma
Start date: 2012-02-02
Rituximab
Indication: Mantle Cell Lymphoma
Start date: 2012-02-01
Treanda
Indication: Mantle Cell Lymphoma
Start date: 2012-02-01
Other drugs received by patient: Pegfilgrastim
Possible Dexamethasone side effects in female
Reported by a physician from France on 2012-08-21
Patient: female, weighing 45.0 kg (99.0 pounds)
Reactions: Dyspnoea, Pleural Effusion, Pyrexia, Generalised Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bortezomib
Dosage: 1.82 milligram daily;
Indication: Mantle Cell Lymphoma
Start date: 2012-02-02
Dexamethasone
Indication: Mantle Cell Lymphoma
Start date: 2012-02-02
Rituximab
Indication: Mantle Cell Lymphoma
Start date: 2012-02-01
Treanda
Indication: Mantle Cell Lymphoma
Start date: 2012-02-01
Other drugs received by patient: Pegfilgrastim
Possible Dexamethasone side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16
Patient: female, weighing 87.8 kg (193.2 pounds)
Reactions: Neuropathy Peripheral, Upper Respiratory Tract Infection, Urinary Tract Infection, Pleural Effusion, Pyrexia, Leukocytosis, Sinusitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Mantle Cell Lymphoma
Cytarabine
Dosage: 1.87 g, cyclic
Indication: Mantle Cell Lymphoma
Dexamethasone
Dosage: 40 mg, unk
Administration route: Oral
Indication: Mantle Cell Lymphoma
Doxorubicin Hydrochloride
Dosage: 50 mg/m2, unk
Indication: Mantle Cell Lymphoma
Mesna
Dosage: 600 mg/m2, unk
Indication: Mantle Cell Lymphoma
Methotrexate
Indication: Mantle Cell Lymphoma
Rituximab
Dosage: 1 mg/m2, cyclic
Indication: Mantle Cell Lymphoma
Velcade
Dosage: 0.7 mg/m2, cyclic
Start date: 2012-03-19
Velcade
Dosage: 2.77 mg, cyclic
Indication: Mantle Cell Lymphoma
Start date: 2011-12-31
Velcade
Dosage: 0.7 mg/m2, cyclic
Velcade
Dosage: 0.7 mg/m2, cyclic
Start date: 2012-02-26
Vincristine
Dosage: 2 mg, cyclic
Indication: Mantle Cell Lymphoma
Other drugs received by patient: Sennosides A+B; Nystatin; Diphenhydramine Hydrochloride; Neupogen; Fluconazole; Zofran; Valtrex; Sodium Chloride; Meperidine HCL; Potassium Chloride; Leucovorin Calcium; Zofran; Sodium Chloride; Sodium Chloride; Sodium Chloride; Heparin; Leucovorin Calcium; Allopurinol; Lovenox; Morphine; Senokot; Cipro / 00042702 /; Lovenox; Prednisolone Acetate; Stomatologicals, Mouth Preparations; Tramadol; Sodium Bicarbonate
Possible Dexamethasone side effects in male
Reported by a physician from United States on 2012-08-15
Patient: male
Reactions: Streptococcal Bacteraemia, Otitis Media, Neutropenia, Pyrexia, Sinusitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bms833923
Dosage: 90 mg
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-05-20
Dexamethasone
Dosage: 40 mg
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-04-01
End date: 2011-04-05
Dexamethasone
Administration route: Oral
Start date: 2011-04-01
Lenalidomide
Dosage: 10 mg
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-04-01
End date: 2011-04-05
Lenalidomide
Administration route: Oral
Start date: 2011-04-01
Other drugs received by patient: Aspirin; Neurontin; Multi-Vitamins; Senokot; Clonazepam; Ativan; Calcium; Neurontin; Calcium and Vitamin D; Magnesium; Clonopin
Possible Dexamethasone side effects in 29 year old female
Reported by a health professional (non-physician/pharmacist) from Hungary on 2012-08-14
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Oophoritis, Cytomegalovirus Infection, Pancytopenia, Pyrexia, Pneumonia Cytomegaloviral
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: Hodgkin's Disease
Carboplatin
Indication: Hodgkin's Disease
Cisplatin
Indication: Hodgkin's Disease
Cytarabine
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Dexamethasone
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Indication: Hodgkin's Disease
Etoposide
Indication: Hodgkin's Disease
Gemcitabine Hydrochloride
Indication: Hodgkin's Disease
Ifosfamide
Indication: Hodgkin's Disease
Rituximab
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Vinorelbine
Indication: Hodgkin's Disease
Other drugs received by patient: Radiotherapy
Possible Dexamethasone side effects in 29 year old female
Reported by a health professional (non-physician/pharmacist) from Hungary on 2012-08-14
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Oophoritis, Pancytopenia, Cytomegalovirus Infection, Pyrexia, Pneumonia Cytomegaloviral
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: Hodgkin's Disease
Carboplatin
Indication: Hodgkin's Disease
Cisplatin
Indication: Hodgkin's Disease
Cytarabine
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Dexamethasone
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Indication: Hodgkin's Disease
Etoposide
Indication: Hodgkin's Disease
Gemcitabine Hydrochloride
Indication: Hodgkin's Disease
Ifosfamide
Indication: Hodgkin's Disease
Rituximab
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Vinorelbine
Indication: Hodgkin's Disease
Other drugs received by patient: Radiotherapy
Possible Dexamethasone side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-09
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: Systemic Inflammatory Response Syndrome, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bortezomib
Start date: 2011-08-09
Bortezomib
End date: 2012-02-16
Dexamethasone
Start date: 2011-08-09
Dexamethasone
End date: 2012-02-17
Revlimid
Administration route: Oral
Start date: 2011-08-09
Revlimid
Administration route: Oral
End date: 2012-02-09
Other drugs received by patient: Valacyclovir Hydrochloride; Bactrim
Possible Dexamethasone side effects in 65 year old female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-08-06
Patient: 65 year old female, weighing 62.0 kg (136.4 pounds)
Reactions: Hypersensitivity, Pain, Anaemia, Rash, Multiple Myeloma, Pyrexia, Constipation, Fatigue, Granulocytopenia, Thrombocytopenia, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Indication: Myeloma Recurrence
Start date: 2009-10-01
End date: 2009-10-21
Revlimid
Administration route: Oral
Indication: Myeloma Recurrence
Start date: 2009-10-01
End date: 2009-10-21
Other drugs received by patient: Filgrastim; Levofloxacin; Levofloxacin; Filgrastim; Filgrastim; Filgrastim; Ribodronat; Heparin
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06
Patient:
Reactions: Anaphylactic Reaction, Pyrexia, Headache, Hyperhidrosis, Oedema Peripheral, Cough, Muscle Spasms, Diverticular Perforation, Back Pain, Pneumonia, Anaemia, Insomnia, Neutropenia, Stridor, Chills, Constipation, Hypokalaemia, Disease Progression, Fatigue, Dizziness, Thrombocytopenia, Enteritis, Dyspnoea, Nausea, Lymphopenia, Atrial Fibrillation, Febrile Neutropenia, Rash, Lung Disorder, Diarrhoea, Arthralgia, Sepsis, Bradycardia, Asthenia
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Indication: Multiple Myeloma
Elotuzumab
Dosage: 5, 10 and 20 mg/kg
Indication: Multiple Myeloma
Elotuzumab
Dosage: 5, 10 and 20 mg/kg
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Possible Dexamethasone side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06
Patient: female, weighing 46.0 kg (101.2 pounds)
Reactions: Back Pain, Urinary Incontinence, Muscular Weakness, Pyrexia, Disorientation, Feeling Cold
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 32 mg, cyclic
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-01-03
End date: 2012-03-17
Velcade
Dosage: 1.5 mg, cyclic
Indication: Multiple Myeloma
Start date: 2012-03-04
End date: 2012-03-23
Other drugs received by patient: Losartan Potassium; Omeprazole; Miralax; Reglan; Senna-S / 01035001 /; Methadone HCL; Zofran; Valtrex; Dilaudid
Possible Dexamethasone side effects in 60 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-03
Patient: 60 year old female
Reactions: Vascular Occlusion, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-18
End date: 2012-05-25
Dexamethasone
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-18
End date: 2012-05-21
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-18
End date: 2012-05-26
Possible Dexamethasone side effects in
Reported by a physician from Italy on 2012-08-03
Patient:
Reactions: Pyrexia, Constipation, Disease Progression, Liver Disorder, Herpes Zoster, Cardiac Disorder, Death, Neuropathy Peripheral, Oedema, Thrombocytopenia, Hyperglycaemia, Toxicity To Various Agents, Rash, Gastrointestinal Disorder, Pancreatitis, Deep Vein Thrombosis, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bortezomib
Dosage: 1.3 milligram/sq. meter
Bortezomib
Dosage: 1.3 milligram/sq. meter
Indication: Multiple Myeloma
Bortezomib
Dosage: 1 milligram/sq. meter
Bortezomib
Dosage: .7 milligram/sq. meter
Dexamethasone
Dosage: 40 milligram
Dexamethasone
Dosage: 40 milligram
Indication: Multiple Myeloma
Dexamethasone
Dosage: 40 milligram
Dexamethasone
Dosage: 40 milligram
Dexamethasone
Dosage: 40 milligram
Thalidomide
Dosage: 100 milligram
Administration route: Oral
Thalidomide
Dosage: 200 milligram
Administration route: Oral
Thalidomide
Dosage: 50 milligram
Administration route: Oral
Thalidomide
Dosage: 100 milligram
Administration route: Oral
Thalidomide
Dosage: 100 milligram
Administration route: Oral
Indication: Multiple Myeloma
Other drugs received by patient: Acyclovir; Melphalan Hydrochloride; Neupogen; Neupogen; Cyclophosphamide
Possible Dexamethasone side effects in female
Reported by a physician from Belgium on 2012-08-03
Patient: female, weighing 62.0 kg (136.4 pounds)
Reactions: Anaemia, Febrile Neutropenia, Pyrexia, Lung Squamous Cell Carcinoma Stage Unspecified, Thrombocytopenia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Administration route: Oral
Start date: 2011-06-24
End date: 2011-07-20
Dexamethasone
Start date: 2012-07-04
Dexamethasone
Administration route: Oral
Start date: 2012-04-26
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Start date: 2012-05-31
Dexamethasone
Start date: 2012-07-02
Dexamethasone
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-01-05
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
End date: 2012-06-27
Dexamethasone
Start date: 2012-07-03
Revlimid
Administration route: Oral
Start date: 2011-02-03
End date: 2011-04-20
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2012-04-26
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-06-24
End date: 2011-12-28
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2012-05-30
End date: 2012-06-27
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2012-02-02
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2012-05-31
Revlimid
Dosage: 10 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-01-05
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2011-04-28
End date: 2011-06-16
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2012-01-05
End date: 2012-01-25
Other drugs received by patient: Aspirin; Cranberry Extract; RED Blood Cells; Paracodeine; Omeprazole; Pantoprazole; Flexium; Meropenem; Symbicort; Flexium; Cetavlex; Polyethylene Glycol; Sodium Chloride; Duovent; Aspirin; Bisoprolol Fumarate; R Calm Creme; RED Blood Cells; Platelets; Platelets; Whole Blood; Paracodeine
Possible Dexamethasone side effects in female
Reported by a individual with unspecified qualification from United States on 2012-07-31
Patient: female, weighing 29.9 kg (65.8 pounds)
Reactions: Sphingomonas Paucimobilis Infection, Contusion, Clostridium Test Positive, Tachycardia, Rectal Haemorrhage, Pyrexia, Resuscitation, Heart Rate Decreased, Balance Disorder, Abdominal Distension, Pain in JAW, Lethargy
Adverse event resulted in: death
Drug(s) suspected as cause:
Cytarabine
Dosage: 70 mg
End date: 2012-07-12
Daunorubicin HCL
Dosage: 52 mg
End date: 2012-07-20
Dexamethasone
Dosage: 132 mg
End date: 2012-07-23
Methotrexate
Dosage: 12 mg
End date: 2012-07-20
PEG-L-Asparaginase (Pegaspargase, Oncospar)
Dosage: 2680 mg
End date: 2012-07-16
Vincristine Sulfate
Dosage: 3.1 mg
End date: 2012-07-20
Possible Dexamethasone side effects in 78 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30
Patient: 78 year old female, weighing 46.0 kg (101.2 pounds)
Reactions: Back Pain, Urinary Incontinence, Muscular Weakness, Disorientation, Pyrexia, Feeling Cold
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 32 mg, cyclic
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-01-03
End date: 2012-03-17
Velcade
Dosage: 1.5 mg, cyclic
Indication: Multiple Myeloma
Start date: 2012-03-04
End date: 2012-03-23
Other drugs received by patient: Zofran; Losartan Potassium; Miralax; Dilaudid; Methadone HCL; Reglan; Senna-S / 01035001 /; Omeprazole; Valtrex
Possible Dexamethasone side effects in female
Reported by a physician from Belgium on 2012-07-30
Patient: female, weighing 62.6 kg (137.7 pounds)
Reactions: Anaemia, Febrile Neutropenia, Platelet Count Decreased, Pyrexia, Lung Squamous Cell Carcinoma Stage Unspecified
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Start date: 2012-07-02
Dexamethasone
Start date: 2012-07-03
Dexamethasone
Administration route: Oral
Start date: 2011-06-24
End date: 2011-07-20
Dexamethasone
Administration route: Oral
Start date: 2012-04-26
Dexamethasone
Start date: 2012-07-04
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Start date: 2012-05-31
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
End date: 2012-06-27
Dexamethasone
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-01-05
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2011-04-28
End date: 2011-06-16
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2012-01-05
End date: 2012-01-25
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2012-02-02
Revlimid
Administration route: Oral
Start date: 2011-02-03
End date: 2011-04-20
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-06-24
End date: 2011-12-28
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2012-04-26
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2012-05-31
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2012-05-30
End date: 2012-06-27
Revlimid
Dosage: 10 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-01-05
Other drugs received by patient: R Calm Creme; RED Blood Cells; Cetavlex; Flexium; Platelets; Polyethylene Glycol; Aspirin; Meropenem; Bisoprolol Fumarate; Flexium; Sodium Chloride; Symbicort; Cranberry Extract; Pantoprazole
Possible Dexamethasone side effects in male
Reported by a individual with unspecified qualification from United States on 2012-07-30
Patient: male, weighing 15.6 kg (34.3 pounds)
Reactions: Neutropenia, Pyrexia
Drug(s) suspected as cause:
Daunorubicin HCL
Dosage: 47.25 mg
End date: 2012-07-26
Dexamethasone
Dosage: 42 mg
End date: 2012-07-25
Methotrexate
Dosage: 24 mg
End date: 2012-07-24
PEG-L-Asparaginase (Pegaspargase, Oncospar)
Dosage: 1597.5 mg
End date: 2012-07-16
Vincristine Sulfate
Dosage: 2.85 mg
End date: 2012-07-26
Possible Dexamethasone side effects in
Reported by a physician from Netherlands on 2012-07-30
Patient:
Reactions: Diarrhoea, Pyrexia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1000 mg, unk
Indication: Multiple Myeloma
Start date: 2012-05-04
End date: 2012-05-11
Dexamethasone
Dosage: 40 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-04
End date: 2012-05-15
Velcade
Dosage: 2.6 mg, unk
Indication: Multiple Myeloma
Start date: 2012-05-04
End date: 2012-05-14
Possible Dexamethasone side effects in
Reported by a physician from Israel on 2012-07-28
Patient:
Reactions: Febrile Neutropenia, Hyponatraemia, Pyrexia, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Blinded Ondansetron HCL
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Blinded Ondansetron HCL
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Blinded Post Trial Therapy
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Blinded Post Trial Therapy
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Blinded PRE Trial Therapy
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Blinded PRE Trial Therapy
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Cisplatin
Dosage: 46.2 mg/kg, qd
Indication: Chemotherapy
Start date: 2012-06-18
End date: 2012-06-18
Cytoxan
Dosage: 172 mg, qd
Indication: Chemotherapy
Start date: 2012-06-19
End date: 2012-06-20
Dexamethasone
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Dexamethasone
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Etoposide
Dosage: 33 mg, qd
Indication: Chemotherapy
Start date: 2012-06-18
End date: 2012-06-20
Ondansetron
Administration route: Oral
Indication: Prophylaxis of Nausea and Vomiting
Start date: 2012-06-18
End date: 2012-06-22
Placebo
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Placebo
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Vincristine Sulfate
Dosage: 0.6 mg, qd
Start date: 2012-06-24
End date: 2012-06-24
Vincristine Sulfate
Dosage: 0.66 mg, qd
Start date: 2012-07-01
End date: 2012-07-01
Vincristine Sulfate
Dosage: 0.66 mg, qd
Indication: Chemotherapy
Start date: 2012-06-18
End date: 2012-06-18
Other drugs received by patient: Dexacort (Dexamethasone Sodium Phosphate); Mesna; Resprim; Diamox
Possible Dexamethasone side effects in 40 year old female
Reported by a physician from United States on 2012-07-27
Patient: 40 year old female, weighing 69.5 kg (152.9 pounds)
Reactions: Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bortezomib
Dosage: 1.3mgm2 cyclic
Indication: Amyloidosis
Start date: 2012-04-17
End date: 2012-06-18
Dexamethasone
Dosage: 20mg cyclic
Indication: Amyloidosis
Start date: 2012-04-17
End date: 2012-05-18
Melphalan Hydrochloride
Indication: Amyloidosis
Start date: 2012-06-12
End date: 2012-06-13
Other drugs received by patient: Prilosec; Prochlorperazine Maleate; Lasix; Klor-CON; Tazorac; Ativan; Duac; Imodium; Minocycline HCL; Lupron Depot; Acyclovir; Prevident
Possible Dexamethasone side effects in male
Reported by a individual with unspecified qualification from United States on 2012-07-25
Patient: male, weighing 15.5 kg (34.1 pounds)
Reactions: Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Daunorubicin HCL
Dosage: 31 mg
End date: 2012-07-19
Dexamethasone
Dosage: 24 mg
End date: 2012-07-21
Possible Dexamethasone side effects in female
Reported by a physician from France on 2012-07-25
Patient: female, weighing 45.0 kg (99.0 pounds)
Reactions: Dyspnoea, Pleural Effusion, Pyrexia, Generalised Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bortezomib
Dosage: 1.82 milligram;
Indication: Mantle Cell Lymphoma
Start date: 2012-02-02
Dexamethasone
Indication: Mantle Cell Lymphoma
Start date: 2012-02-02
Rituximab
Indication: Mantle Cell Lymphoma
Start date: 2012-02-01
Treanda
Indication: Mantle Cell Lymphoma
Start date: 2012-02-01
Other drugs received by patient: Pegfilgrastim
Possible Dexamethasone side effects in male
Reported by a physician from NEW Zealand on 2012-07-24
Patient: male, weighing 70.0 kg (154.0 pounds)
Reactions: Confusional State, Neoplasm Malignant, Neoplasm Progression, Pyrexia, Metastases To Central Nervous System, Blood Glucose Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 4 mg, qd
Administration route: Oral
Start date: 2008-10-15
Zoledronoc Acid
Dosage: 4.0mg
Indication: Prostate Cancer
Start date: 2008-09-27
Other drugs received by patient: Vitamin D; Calcium
Possible Dexamethasone side effects in female
Reported by a physician from Belgium on 2012-07-23
Patient: female, weighing 62.6 kg (137.7 pounds)
Reactions: Pyrexia, Lung Squamous Cell Carcinoma Stage Unspecified
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Administration route: Oral
Start date: 2012-04-26
Dexamethasone
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-01-05
Dexamethasone
Start date: 2012-07-03
Dexamethasone
Administration route: Oral
Start date: 2011-06-24
End date: 2011-07-20
Dexamethasone
Start date: 2012-07-02
Dexamethasone
Start date: 2012-07-04
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2011-04-28
End date: 2011-06-16
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-06-24
End date: 2011-12-28
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2012-04-26
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2012-01-05
End date: 2012-01-25
Revlimid
Dosage: 10 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-01-05
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2012-02-02
Revlimid
Administration route: Oral
Start date: 2011-02-03
End date: 2011-04-20
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2012-05-31
Other drugs received by patient: Pantoprazole; Cranberry Extract; Aspirin; Flexium; Sodium Chloride; R Calm Creme; Flexium; Meropenem; Polyethylene Glycol; Symbicort; Platelets; Cetavlex; Bisoprolol Fumarate; RED Blood Cells
Possible Dexamethasone side effects in male
Reported by a individual with unspecified qualification from United States on 2012-07-23
Patient: male, weighing 54.0 kg (118.8 pounds)
Reactions: White Blood Cell Count Decreased, Pneumonia, Chills, Anaemia, Febrile Neutropenia, Pyrexia, Oropharyngeal Pain, Fatigue, Respiratory Failure, Tachypnoea, Cough, Oxygen Saturation Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 135 mg
Mercaptopurine
Dosage: 8000 mg
Methotrexate
Dosage: 270 mg
Possible Dexamethasone side effects in
Reported by a physician from France on 2012-07-19
Patient:
Reactions: Lung Disorder, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 140 mg, unk
Indication: Multiple Myeloma
Start date: 2011-11-04
End date: 2011-11-15
Dexamethasone
Dosage: 20 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-11-04
End date: 2011-11-12
Velcade
Dosage: 2.4 mg, unk
Indication: Multiple Myeloma
Start date: 2011-11-04
End date: 2012-02-07
Other drugs received by patient: Calciparine; Plavix; Lercanidipine; Ezetimibe; Perindopril Erbumine; ART; Imovane; Bisoprolol Fumarate; Pantoprazole; Klipal / 01259001 /
Possible Dexamethasone side effects in 68 year old female
Reported by a health professional (non-physician/pharmacist) from Austria on 2012-07-18
Patient: 68 year old female, weighing 75.0 kg (165.0 pounds)
Reactions: Ventricular Arrhythmia, Pyrexia, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carfilzomib
Dosage: 50 milligram
Start date: 2011-08-16
End date: 2011-08-17
Carfilzomib
Dosage: 49.7 milligram
Start date: 2011-09-06
End date: 2011-09-07
Carfilzomib
Dosage: 49.7 milligram
Start date: 2011-08-23
End date: 2011-08-24
Carfilzomib
Dosage: 36 milligram
Indication: Multiple Myeloma
Start date: 2011-08-09
End date: 2011-08-10
Carfilzomib
Dosage: 49.7 milligram
Start date: 2011-09-13
End date: 2011-09-14
Dexamethasone
Indication: Multiple Myeloma
Start date: 2011-08-09
End date: 2011-08-30
Dexamethasone
Start date: 2011-09-06
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-08-09
End date: 2011-08-29
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2011-09-08
End date: 2011-09-12
Other drugs received by patient: Ciprofloxacin HCL; Iterium; Pamitor; Pantoprazole Sodium; Lasix; Nebilan; Simvastatin; Glandomed; Calcitonin Salmon; Mycostatin; Urosin; Marcumar; Marcumar; Valtrex; Augmentin '500'
Possible Dexamethasone side effects in female
Reported by a health professional (non-physician/pharmacist) from Spain on 2012-07-18
Patient: female, weighing 84.0 kg (184.8 pounds)
Reactions: Multiple Myeloma, Pyrexia, Headache
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2009-10-15
End date: 2009-11-13
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Start date: 2009-08-18
Revlimid
Dosage: 15 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2009-10-15
End date: 2009-11-13
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2009-08-18
Other drugs received by patient: Omeprazole; Sulphametoxazole / Trimetoprim; Enoxaparin; Heparin Sodium; Acyclovir
Possible Dexamethasone side effects in male
Reported by a physician from Japan on 2012-07-18
Patient: male
Reactions: Bronchopneumonia, Disseminated Intravascular Coagulation, Pyrexia, Constipation, Herpes Zoster, Neuropathy Peripheral, C-Reactive Protein Increased, Thrombocytopenia, Blood Creatinine Increased, Cardiac Failure Congestive, Decreased Appetite, Prothrombin Time Ratio Increased, Dyspnoea, Pneumonia, Anaemia, Muscular Weakness, Lobar Pneumonia, Haemoglobin Decreased, Cerebral Infarction, Sepsis, Platelet Count Decreased, Neutropenia, Neutrophil Count Decreased
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Start date: 2012-01-13
End date: 2012-02-03
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-12-10
End date: 2012-01-07
Prednisolone
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-05-12
End date: 2011-05-25
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Start date: 2011-05-26
End date: 2011-06-01
Prednisolone
Dosage: 10 milligram
Indication: Multiple Myeloma
Start date: 2012-02-09
End date: 2012-02-17
Prednisolone
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-03-31
End date: 2011-04-13
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-24
End date: 2011-03-30
Prednisolone
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-08-17
End date: 2012-02-08
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Start date: 2011-04-21
End date: 2011-05-11
Revlimid
Dosage: 15 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-24
End date: 2011-04-13
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-08-17
End date: 2011-09-06
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-09-14
End date: 2011-10-03
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-10-12
End date: 2011-10-22
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-12-11
End date: 2011-12-31
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2011-04-21
End date: 2011-05-11
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2012-01-25
End date: 2012-02-11
Other drugs received by patient: Glufast; Warfarin Sodium; Famotidine; Mucosta; Flomax; Warfarin Sodium; Magnesium Oxide; Zometa; Lansoprazole; Magnesium Oxide; Slow-K; Glufast; Tamsulosin HCL; Humulin R; Warfarin Sodium; Tamsulosin HCL; SHA-Kanzo-TO; SHA-Kanzo-TO; Levothyroxine Sodium; Diovan; Slow-K; Warfarin Sodium; Mucosta; Diovan; Clarithromycin; Levothyroxine Sodium; Levothyroxine Sodium; Zometa
Possible Dexamethasone side effects in
Reported by a physician from France on 2012-07-18
Patient:
Reactions: Respiratory Tract Infection Fungal, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 mg, unk
Administration route: Oral
Indication: Mantle Cell Lymphoma
Start date: 2008-11-03
End date: 2008-11-06
Doxorubicin HCL
Dosage: 15 mg, unk
Indication: Mantle Cell Lymphoma
Start date: 2008-11-03
End date: 2008-11-06
Rituximab
Dosage: 857 mg, unk
Indication: Mantle Cell Lymphoma
Start date: 2008-11-03
End date: 2008-11-03
Velcade
Dosage: 2 mg, unk
Indication: Mantle Cell Lymphoma
Start date: 2008-11-03
End date: 2008-11-03
Page 1 Next >>
|
